BioStem Technologies, Inc.
BSEM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $31,884 | -$8,483 | -$7,114 | -$1,412 |
| Dep. & Amort. | $293 | $395 | $243 | $284 |
| Deferred Tax | $0 | $0 | $0 | -$689 |
| Stock-Based Comp. | $0 | $6,670 | $4,903 | $403 |
| Change in WC | -$12,011 | -$3,542 | $8 | $516 |
| Other Non-Cash | $4,310 | $1,461 | $323 | $789 |
| Operating Cash Flow | $24,477 | -$3,499 | -$1,637 | -$109 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$427 | -$105 | -$469 | -$43 |
| Net Acquisitions | $0 | -$105 | $0 | $35 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$1,250 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,677 | -$210 | -$469 | -$8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$849 | $797 | $548 | $232 |
| Stock Issued | $643 | $2,380 | $50 | $125 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$392 |
| Financing Cash Flow | -$207 | $3,177 | $598 | $357 |
| Forex Effect | $0 | $0 | $1,965 | $0 |
| Net Chg. in Cash | $22,593 | -$533 | $432 | $240 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $239 | $772 | $340 | $100 |
| End Cash | $22,833 | $239 | $772 | $340 |
| Free Cash Flow | $24,050 | -$3,604 | -$2,106 | -$152 |